Myelofibrosis (MF) clinical trials at UCSD
1 in progress, 0 open to eligible people
A Study Evaluating Tolerability and Efficacy of Navitoclax Alone or in Combination With Ruxolitinib in Participants With Myelofibrosis
Sorry, not currently recruiting here
This is a Phase 2 open-label, multicenter study evaluating tolerability and efficacy of navitoclax alone or when added to ruxolitinib in participants with myelofibrosis.
La Jolla, California and other locations